Affimed Q3 EPS $(0.17) Beats $(0.20) Estimate, Sales $2.14M Beat $2.01M Estimate
Portfolio Pulse from Benzinga Newsdesk
Affimed (NASDAQ:AFMD) reported Q3 earnings with an EPS of $(0.17), surpassing the $(0.20) estimate, and sales of $2.14M, exceeding the $2.01M estimate. However, these figures represent a significant decrease from the previous year, with a 54.55% drop in EPS and an 85.77% decline in sales compared to the same quarter last year.
November 14, 2023 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Affimed's Q3 earnings exceeded analyst expectations on both EPS and sales, but showed significant declines from the previous year's figures.
While Affimed's earnings beat may be viewed positively in the short term, the substantial year-over-year decline in both EPS and sales could raise concerns about the company's growth trajectory and profitability, potentially leading to a neutral impact on the stock price as investors digest both the positive and negative aspects of the report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100